Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study

Ítems similars

• Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
  per: Catto, J, et al.
  Publicat: (2011)
• Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
  per: Rosario, D, et al.
  Publicat: (2008)
• The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
  per: Lane, J, et al.
  Publicat: (2004)
• Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
  per: Hamdy, FC, et al.
  Publicat: (2020)
• Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
  per: Collin, S, et al.
  Publicat: (2009)